GMP IPO Watch
DSP Multi Cap Fund
Regular Plan · Growth · DSP Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +2.00% | +3.33% | 31 of 33 |
| 1M | -0.35% | +1.46% | 31 of 33 |
| 3M | -5.34% | -2.65% | 29 of 32 |
| 6M | -0.07% | +4.05% | 27 of 32 |
| YTD | -3.30% | +1.68% | 29 of 33 |
| 1Y | -3.89% | +1.23% | 28 of 32 |
| 2Y | -2.41% | +2.34% | 24 of 27 |
| INCEPTION | +5.85% | — | — |
Ranked among: Equity Scheme - Multi Cap Fund.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +2.36% | +22.72% | -17.87% | 58% | 22% |
| 6M | +3.42% | +32.93% | -19.40% | 56% | 22% |
| 1Y | +1.95% | +14.47% | -8.43% | 63% | 25% |
| 2Y | +2.12% | +9.28% | -4.53% | 70% | 28% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity95.89%
- Debt0.00%
- Cash4.11%
- Other0.00%
Market Cap Split
- Large Cap33.63%
- Mid Cap29.73%
- Small Cap32.53%
- Others4.11%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 26.01 | 27.14 |
| P/B | 3.32 | 3.97 |
| Price / Sales | 2.35 | 3.29 |
| Price / Cash Flow | 18.54 | 21.02 |
| Dividend Yield (%) | 1.25 | 0.96 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| HDFC Bank | Banks | 6.40% | +0.31% |
| ICICI Bank | Banks | 5.38% | -0.25% |
| TREPS / Reverse Repo Investments | Reverse Repo / TREPS | 4.27% | — |
| Axis Bank | Banks | 3.78% | -0.03% |
| Max Financial Services | Insurance | 3.55% | +0.24% |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 3.26% | +0.26% |
| Info Edge | Retailing | 2.96% | -0.07% |
| Coforge | IT - Software | 2.87% | -0.23% |
| Kirloskar Oil Engines | Industrial Products | 2.83% | +0.37% |
| Mahindra & Mahindra | Automobiles | 2.76% | -0.16% |
| Cipla | Pharmaceuticals & Biotechnology | 2.72% | +0.01% |
| Hero Motocorp | Automobiles | 2.62% | +0.03% |
| ICICI Lombard General Insurance | Insurance | 2.43% | +0.16% |
| APL Apollo Tubes | Industrial Products | 2.43% | +0.08% |
| Gland Pharma | Pharmaceuticals & Biotechnology | 2.25% | +0.12% |
View all 57 holdings
| Physicswallah | Other Consumer Services | 2.09% | +0.22% |
| Coal India | Consumable Fuels | 2.00% | +0.20% |
| ICICI Prudential Life Insurance | Insurance | 1.95% | +0.05% |
| KEI Industries | Industrial Products | 1.93% | -0.44% |
| HDFC AMC | Capital Markets | 1.85% | -0.18% |
| UTI AMC | Capital Markets | 1.75% | +0.10% |
| IPCA Laboratories | Pharmaceuticals & Biotechnology | 1.67% | +0.04% |
| Bharat Petroleum | Petroleum Products | 1.64% | -0.03% |
| Schaeffler India | Auto Components | 1.64% | +0.03% |
| Sai Life Sciences | Pharmaceuticals & Biotechnology | 1.57% | +0.14% |
| Sudarshan Chemical Industries | Chemicals & Petrochemicals | 1.55% | +0.00% |
| Cyient | IT - Services | 1.47% | -0.02% |
| Tube Investment | Auto Components | 1.44% | -0.17% |
| Polycab | Industrial Products | 1.43% | -0.17% |
| Archean Chemical Industries | Chemicals & Petrochemicals | 1.40% | +0.07% |
| Indigo Paints | Consumer Durables | 1.32% | -0.01% |
| Hindustan Aeronautics | Aerospace & Defense | 1.31% | +0.03% |
| Syngene International | Equity | 1.22% | -0.06% |
| Apollo Hospitals | Equity | 1.22% | -0.04% |
| Siemens | Electrical Equipment | 1.19% | -0.03% |
| Emami | Personal Products | 1.17% | +0.11% |
| Bayer Crop Science | Fertilizers & Agrochemicals | 1.11% | -0.05% |
| Century Plyboards | Consumer Durables | 1.07% | -0.06% |
| Cohance Lifesciences | Pharmaceuticals & Biotechnology | 1.07% | +0.03% |
| ITC | Diversified FMCG | 1.05% | +0.08% |
| PG Electroplast | Consumer Durables | 1.02% | -0.13% |
| Canara HSBC Life Insurance Company | Insurance | 1.01% | +0.00% |
| Prince Pipes & Fittings | Industrial Products | 1.00% | -0.09% |
| Jubilant Ingrevia | Chemicals & Petrochemicals | 1.00% | +0.02% |
| JNK India | Industrial Manufacturing | 0.98% | +0.05% |
| Nippon Life India AMC | Capital Markets | 0.98% | -0.04% |
| NTPC | Power | 0.90% | +0.03% |
| Dodla Dairy | Food Products | 0.83% | +0.00% |
| Vardhman Textiles | Textiles & Apparels | 0.80% | -0.01% |
| Gopal Snacks | Food Products | 0.79% | -0.03% |
| Indoco Remedies | Pharmaceuticals & Biotechnology | 0.69% | +0.08% |
| IFGL Refractories | Industrial Products | 0.66% | -0.03% |
| Seshaasai Technologies | Financial Technology (Fintech) | 0.61% | -0.02% |
| IFB Industries | Consumer Durables | 0.48% | -0.09% |
| R Systems International | IT - Services | 0.42% | +0.07% |
| Alembic Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.37% | +0.02% |
| Net Receivables/Payables | Net Current Assets | -0.16% | — |
Sector Allocation · Sep 2026
View all 26 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 14.52 | 15.31 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.57 | -0.33 | Below Average |
| 3Y | 0.04 | 0.32 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.28 | 0.21 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Beta
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.01 | 0.97 | Poor Risk Adjusted Returns |
What is this?
This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Groww Multicap Fund
Direct Plan · Growth
|
+13.63% | — | — | +11.87% |
|
TRUSTMF MULTI CAP FUND
Direct Plan · Growth
|
+12.34% | — | — | +13.94% |
|
ITI Multi Cap Fund
Direct Plan · Growth Option
|
+9.77% | +16.97% | +13.88% | +15.71% |
|
BANK OF INDIA MULTI CAP FUND
Direct Plan · Growth
|
+7.33% | +17.10% | — | +21.39% |
|
Axis Multicap Fund
Regular Plan · Growth Option
|
+6.43% | +17.92% | — | +14.74% |
|
Motilal Oswal Multi Cap Fund
Regular plan · IDCW
|
+6.12% | — | — | +16.17% |
|
PGIM India Multi Cap Fund
Direct Plan · Direct Growth
|
+6.04% | — | — | +3.63% |
|
Bajaj Finserv Multi Cap Fund
Direct Plan · IDCW
|
+5.98% | — | — | +12.47% |
|
LIC MF Multi Cap Fund
Direct Plan · Growth
|
+4.70% | +17.74% | — | +17.85% |
|
Union Multicap Fund
Regular Plan · Growth Option
|
+4.69% | +13.67% | — | +15.93% |
More From DSP Asset Managers Private Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
DSP World Mining Overseas Equity Omni FoF
Direct Plan · Growth
|
+30.57% | +26.29% | +17.28% | +8.14% |
| DSP Silver ETF | +25.96% | +36.34% | — | +31.49% |
|
DSP Silver ETF Fund of Fund
Direct Plan · IDCW
|
+24.85% | — | — | +54.98% |
|
DSP US Specific Equity Omni FoF
Direct Plan · Growth
|
+21.65% | +27.47% | +17.63% | +17.56% |
|
DSP World Gold Mining Overseas Equity Omni FoF
Direct Plan · IDCW
|
+21.32% | +42.73% | +20.32% | +5.96% |
|
DSP Global Clean Energy Overseas Equity Omni FoF
Direct Plan · Growth
|
+17.43% | +19.84% | +8.83% | +6.79% |
| DSP Gold ETF | +16.97% | +31.00% | — | +26.42% |
|
DSP Gold ETF Fund of Fund
Direct Plan · IDCW
|
+16.95% | — | — | +31.09% |
|
DSP Healthcare Fund
Direct Plan · Growth
|
+15.22% | +21.49% | +16.24% | +22.63% |
| DSP Nifty Healthcare ETF | +13.41% | — | — | +15.38% |
About This Scheme
Investment Objective
The investment objective of the scheme is to seek to generate long-term capital appreciation from a portfolio of equity and equity related securities across market capitalization. There is no assurance that the investment objective of the Scheme will be achieved.
Stated Asset Allocation
A. Equity and Equity related Instruments of which#: : 75% - 100% of which: (i) Large cap companies/ entities : 25% - 50%; (ii) Mid cap companies/ entities : 25% - 50%; (iii) Small cap companies/ entities : 25% - 50%. B. Equity and Equity related overseas securities/ Money Market Instruments / InvITs/ Gold ETFs / Silver ETFs / Other Liquid Instruments / Units of Domestic Mutual Funds^ : 0% - 25% For detailed asset allocation pattern, please refer to the Scheme Information Document #For the purpose of identifying large cap, mid cap and small cap companies/entities, the communication issued by SEBI and AMFI shall be considered. As per paragraph 3.9 of the SEBI Master Circular, the definition of large cap, mid cap and small cap shall be as follows: Large Cap: 1st -100th entities in terms of full market capitalization Mid Cap: 101st -250th entities in terms of full market capitalization Small Cap: 251st entities onwards in terms of full market capitalization Accordingly, mutual funds are required to adopt the list of such stocks prepared and published by AMFI. ^Any other security as may be permitted by SEBI/ RBI from time to time. Other Liquid instruments includes cash, bank deposits with Scheduled Commercial Banks, Government Securities, Treasury bills, Repo on Government securities and any other instruments as specified by the SEBI. The scheme may invest in the units of Overnight Fund, Money Market Fund & Liquid Fund (including Liquid ETFs) of Domestic Mutual Fund.
Exit Load
Exit Load (as a % of Applicable NAV): Holding period from the date of allotment: < 12 months - 1% >=12 month – Nil
Fund Managers
Mr. Chirag Dagli
Mr. Chirag Dagli - Primary (Equity and Overseas portion)
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.